不眠症治療の世界市場、2024～2028年

不眠症治療市場は2023～2028年に11億340万米ドル、予測期間中のCAGRは5.72％で成長すると予測されます。

当レポートでは、不眠症治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、不眠症の有病率の増加、診断と治療における技術進歩、医療支出と保険適用の増加によって牽引されています。

本調査では、今後数年間の不眠症治療市場の成長を促進する主要要因の1つとして、非薬剤療法への注目の高まりを挙げています。また、睡眠モニタリングとトラッキングの技術的進歩、メンタルヘルスの重要性に対する認識と受容の高まりは、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023年
• 市場の展望 2023～2028年

第4章 市場規模実績

• 不眠症治療の世界市場 2018～2022年
• タイプ別セグメント分析 2018～2022年
• 流通チャネル別セグメント分析 2018～2022年
• 地域別セグメント分析 2018～2022年
• 国別セグメント分析 2018～2022年

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 タイプ別市場セグメンテーション

• 市場セグメンテーション
• 比較：タイプ別
• 薬剤：市場規模と予測 2023～2028年
• 装置：市場規模と予測 2023～2028年
• タイプ別の市場機会

第7章 流通チャネル別市場セグメンテーション

• 市場セグメンテーション
• 比較：流通チャネル別
• 処方：市場規模と予測 2023～2028年
• 市販：市場規模と予測 2023～2028年
• 流通チャネル別の市場機会

第8章 顧客情勢

• 顧客情勢概要

第9章 地域別情勢

• 地域別セグメンテーション
• 比較：地域別
• 北米：市場規模と予測 2023～2028年
• アジア：市場規模と予測 2023～2028年
• 欧州：市場規模と予測 2023～2028年
• その他：市場規模と予測 2023～2028年
• 米国：市場規模と予測 2023～2028年
• カナダ：市場規模と予測 2023～2028年
• 日本：市場規模と予測 2023～2028年
• フランス：市場規模と予測 2023～2028年
• ドイツ：市場規模と予測 2023～2028年
• 地域情勢別の市場機会

第10章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場課題
• 促進要因と課題の影響
• 市場機会・抑制要因

第11章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第12章 競合分析

• 企業プロファイル
• 企業の市場ポジショニング
• Astellas Pharma Inc.
• Aurobindo Pharma Ltd.
• Eisai Co. Ltd.
• Electromedical Products International Inc.
• Idorsia Pharmaceuticals Ltd.
• INNOVATIVE NEUROLOGICAL DEVICES LLC
• Merck and Co. Inc.
• Minerva Neurosciences Inc.
• Neurim Pharmaceuticals Ltd.
• Pfizer Inc.
• Sanofi SA
• Sumitomo Pharma Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Co. Ltd.
• Vanda Pharmaceuticals Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Company Market Positioning
• Exhibits10: Parent Market
• Exhibits11: Data Table on - Parent Market
• Exhibits12: Market characteristics analysis
• Exhibits13: Value Chain Analysis
• Exhibits14: Offerings of companies included in the market definition
• Exhibits15: Market segments
• Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits20: Historic Market Size - Data Table on Global Insomnia Therapeutics Market 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits25: Five forces analysis - Comparison between 2023 and 2028
• Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits31: Chart on Market condition - Five forces 2023 and 2028
• Exhibits32: Chart on Type - Market share 2023-2028 (%)
• Exhibits33: Data Table on Type - Market share 2023-2028 (%)
• Exhibits34: Chart on Comparison by Type
• Exhibits35: Data Table on Comparison by Type
• Exhibits36: Chart on Drug - Market size and forecast 2023-2028 ($ million)
• Exhibits37: Data Table on Drug - Market size and forecast 2023-2028 ($ million)
• Exhibits38: Chart on Drug - Year-over-year growth 2023-2028 (%)
• Exhibits39: Data Table on Drug - Year-over-year growth 2023-2028 (%)
• Exhibits40: Chart on Devices - Market size and forecast 2023-2028 ($ million)
• Exhibits41: Data Table on Devices - Market size and forecast 2023-2028 ($ million)
• Exhibits42: Chart on Devices - Year-over-year growth 2023-2028 (%)
• Exhibits43: Data Table on Devices - Year-over-year growth 2023-2028 (%)
• Exhibits44: Market opportunity by Type ($ million)
• Exhibits45: Data Table on Market opportunity by Type ($ million)
• Exhibits46: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibits47: Data Table on Distribution Channel - Market share 2023-2028 (%)
• Exhibits48: Chart on Comparison by Distribution Channel
• Exhibits49: Data Table on Comparison by Distribution Channel
• Exhibits50: Chart on Prescription - Market size and forecast 2023-2028 ($ million)
• Exhibits51: Data Table on Prescription - Market size and forecast 2023-2028 ($ million)
• Exhibits52: Chart on Prescription - Year-over-year growth 2023-2028 (%)
• Exhibits53: Data Table on Prescription - Year-over-year growth 2023-2028 (%)
• Exhibits54: Chart on OTC - Market size and forecast 2023-2028 ($ million)
• Exhibits55: Data Table on OTC - Market size and forecast 2023-2028 ($ million)
• Exhibits56: Chart on OTC - Year-over-year growth 2023-2028 (%)
• Exhibits57: Data Table on OTC - Year-over-year growth 2023-2028 (%)
• Exhibits58: Market opportunity by Distribution Channel ($ million)
• Exhibits59: Data Table on Market opportunity by Distribution Channel ($ million)
• Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits63: Chart on Geographic comparison
• Exhibits64: Data Table on Geographic comparison
• Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits69: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits71: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits72: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits86: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits87: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits90: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits91: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits93: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibits94: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibits95: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits96: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits101: Market opportunity By Geographical Landscape ($ million)
• Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits103: Impact of drivers and challenges in 2023 and 2028
• Exhibits104: Overview on criticality of inputs and factors of differentiation
• Exhibits105: Overview on factors of disruption
• Exhibits106: Impact of key risks on business
• Exhibits107: Companies covered
• Exhibits108: Matrix on companies position and classification
• Exhibits109: Astellas Pharma Inc. - Overview
• Exhibits110: Astellas Pharma Inc. - Product / Service
• Exhibits111: Astellas Pharma Inc. - Key offerings
• Exhibits112: Aurobindo Pharma Ltd. - Overview
• Exhibits113: Aurobindo Pharma Ltd. - Product / Service
• Exhibits114: Aurobindo Pharma Ltd. - Key offerings
• Exhibits115: Eisai Co. Ltd. - Overview
• Exhibits116: Eisai Co. Ltd. - Business segments
• Exhibits117: Eisai Co. Ltd. - Key offerings
• Exhibits118: Eisai Co. Ltd. - Segment focus
• Exhibits119: Electromedical Products International Inc. - Overview
• Exhibits120: Electromedical Products International Inc. - Product / Service
• Exhibits121: Electromedical Products International Inc. - Key offerings
• Exhibits122: Idorsia Pharmaceuticals Ltd. - Overview
• Exhibits123: Idorsia Pharmaceuticals Ltd. - Product / Service
• Exhibits124: Idorsia Pharmaceuticals Ltd. - Key offerings
• Exhibits125: INNOVATIVE NEUROLOGICAL DEVICES LLC - Overview
• Exhibits126: INNOVATIVE NEUROLOGICAL DEVICES LLC - Product / Service
• Exhibits127: INNOVATIVE NEUROLOGICAL DEVICES LLC - Key offerings
• Exhibits128: Merck and Co. Inc. - Overview
• Exhibits129: Merck and Co. Inc. - Business segments
• Exhibits130: Merck and Co. Inc. - Key news
• Exhibits131: Merck and Co. Inc. - Key offerings
• Exhibits132: Merck and Co. Inc. - Segment focus
• Exhibits133: Minerva Neurosciences Inc. - Overview
• Exhibits134: Minerva Neurosciences Inc. - Product / Service
• Exhibits135: Minerva Neurosciences Inc. - Key offerings
• Exhibits136: Neurim Pharmaceuticals Ltd. - Overview
• Exhibits137: Neurim Pharmaceuticals Ltd. - Product / Service
• Exhibits138: Neurim Pharmaceuticals Ltd. - Key offerings
• Exhibits139: Pfizer Inc. - Overview
• Exhibits140: Pfizer Inc. - Product / Service
• Exhibits141: Pfizer Inc. - Key news
• Exhibits142: Pfizer Inc. - Key offerings
• Exhibits143: Sanofi SA - Overview
• Exhibits144: Sanofi SA - Business segments
• Exhibits145: Sanofi SA - Key news
• Exhibits146: Sanofi SA - Key offerings
• Exhibits147: Sanofi SA - Segment focus
• Exhibits148: Sumitomo Pharma Co. Ltd. - Overview
• Exhibits149: Sumitomo Pharma Co. Ltd. - Business segments
• Exhibits150: Sumitomo Pharma Co. Ltd. - Key offerings
• Exhibits151: Sumitomo Pharma Co. Ltd. - Segment focus
• Exhibits152: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibits153: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibits154: Sun Pharmaceutical Industries Ltd. - Key news
• Exhibits155: Sun Pharmaceutical Industries Ltd. - Key offerings
• Exhibits156: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits157: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits158: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits159: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits160: Vanda Pharmaceuticals Inc. - Overview
• Exhibits161: Vanda Pharmaceuticals Inc. - Product / Service
• Exhibits162: Vanda Pharmaceuticals Inc. - Key offerings
• Exhibits163: Inclusions checklist
• Exhibits164: Exclusions checklist
• Exhibits165: Currency conversion rates for US$
• Exhibits166: Research methodology
• Exhibits167: Information sources
• Exhibits168: Data validation
• Exhibits169: Validation techniques employed for market sizing
• Exhibits170: Data synthesis
• Exhibits171: 360 degree market analysis
• Exhibits172: List of abbreviations

The insomnia therapeutics market is forecasted to grow by USD 1103.4 mn during 2023-2028, accelerating at a CAGR of 5.72% during the forecast period. The report on the insomnia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of insomnia, technological advancements in diagnostics and treatment, and rising healthcare expenditure and insurance coverage.

Technavio's insomnia therapeutics market is segmented as below:

By Type

• Drug
• Devices

By Distribution Channel

• Prescription
• OTC

By Geographical Landscape

• North America
• Asia
• Europe
• Rest of World (ROW)

This study identifies the increased focus on non-pharmacological treatments as one of the prime reasons driving the insomnia therapeutics market growth during the next few years. Also, technological advancements in sleep monitoring and tracking and growing awareness and acceptance of importance of mental health will lead to sizable demand in the market.

The report on the insomnia therapeutics market covers the following areas:

• Insomnia therapeutics market sizing
• Insomnia therapeutics market forecast
• Insomnia therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading insomnia therapeutics market vendors that include Abbott Laboratories, Astellas Pharma Inc., Aurobindo Pharma Ltd., Eisai Co. Ltd., Electromedical Products International Inc., Idorsia Pharmaceuticals Ltd., INNOVATIVE NEUROLOGICAL DEVICES LLC, Mallinckrodt Plc, MEDICE Arzneimittel Putter GmbH and Co. KG, Merck and Co. Inc., Minerva Neurosciences Inc., Neurim Pharmaceuticals Ltd., Pfizer Inc., Questex LLC, Sanofi SA, Sumitomo Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Vanda Pharmaceuticals Inc., and Viatris Inc.. Also, the insomnia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Insomnia Therapeutics Market 2018 - 2022
  • Historic Market Size - Data Table on Global Insomnia Therapeutics Market 2018 - 2022 ($ million)
• 4.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.3 Distribution Channel segment analysis 2018 - 2022
  • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 6.3 Drug - Market size and forecast 2023-2028
  • Chart on Drug - Market size and forecast 2023-2028 ($ million)
  • Data Table on Drug - Market size and forecast 2023-2028 ($ million)
  • Chart on Drug - Year-over-year growth 2023-2028 (%)
  • Data Table on Drug - Year-over-year growth 2023-2028 (%)
• 6.4 Devices - Market size and forecast 2023-2028
  • Chart on Devices - Market size and forecast 2023-2028 ($ million)
  • Data Table on Devices - Market size and forecast 2023-2028 ($ million)
  • Chart on Devices - Year-over-year growth 2023-2028 (%)
  • Data Table on Devices - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
  • Chart on Distribution Channel - Market share 2023-2028 (%)
  • Data Table on Distribution Channel - Market share 2023-2028 (%)
• 7.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 7.3 Prescription - Market size and forecast 2023-2028
  • Chart on Prescription - Market size and forecast 2023-2028 ($ million)
  • Data Table on Prescription - Market size and forecast 2023-2028 ($ million)
  • Chart on Prescription - Year-over-year growth 2023-2028 (%)
  • Data Table on Prescription - Year-over-year growth 2023-2028 (%)
• 7.4 OTC - Market size and forecast 2023-2028
  • Chart on OTC - Market size and forecast 2023-2028 ($ million)
  • Data Table on OTC - Market size and forecast 2023-2028 ($ million)
  • Chart on OTC - Year-over-year growth 2023-2028 (%)
  • Data Table on OTC - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.5 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.9 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.10 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ million)
  • Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.11 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 Astellas Pharma Inc.
  • Astellas Pharma Inc. - Overview
  • Astellas Pharma Inc. - Product / Service
  • Astellas Pharma Inc. - Key offerings
• 12.4 Aurobindo Pharma Ltd.
  • Aurobindo Pharma Ltd. - Overview
  • Aurobindo Pharma Ltd. - Product / Service
  • Aurobindo Pharma Ltd. - Key offerings
• 12.5 Eisai Co. Ltd.
  • Eisai Co. Ltd. - Overview
  • Eisai Co. Ltd. - Business segments
  • Eisai Co. Ltd. - Key offerings
  • Eisai Co. Ltd. - Segment focus
• 12.6 Electromedical Products International Inc.
  • Electromedical Products International Inc. - Overview
  • Electromedical Products International Inc. - Product / Service
  • Electromedical Products International Inc. - Key offerings
• 12.7 Idorsia Pharmaceuticals Ltd.
  • Idorsia Pharmaceuticals Ltd. - Overview
  • Idorsia Pharmaceuticals Ltd. - Product / Service
  • Idorsia Pharmaceuticals Ltd. - Key offerings
• 12.8 INNOVATIVE NEUROLOGICAL DEVICES LLC
  • INNOVATIVE NEUROLOGICAL DEVICES LLC - Overview
  • INNOVATIVE NEUROLOGICAL DEVICES LLC - Product / Service
  • INNOVATIVE NEUROLOGICAL DEVICES LLC - Key offerings
• 12.9 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
• 12.10 Minerva Neurosciences Inc.
  • Minerva Neurosciences Inc. - Overview
  • Minerva Neurosciences Inc. - Product / Service
  • Minerva Neurosciences Inc. - Key offerings
• 12.11 Neurim Pharmaceuticals Ltd.
  • Neurim Pharmaceuticals Ltd. - Overview
  • Neurim Pharmaceuticals Ltd. - Product / Service
  • Neurim Pharmaceuticals Ltd. - Key offerings
• 12.12 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
• 12.13 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
• 12.14 Sumitomo Pharma Co. Ltd.
  • Sumitomo Pharma Co. Ltd. - Overview
  • Sumitomo Pharma Co. Ltd. - Business segments
  • Sumitomo Pharma Co. Ltd. - Key offerings
  • Sumitomo Pharma Co. Ltd. - Segment focus
• 12.15 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
• 12.16 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
• 12.17 Vanda Pharmaceuticals Inc.
  • Vanda Pharmaceuticals Inc. - Overview
  • Vanda Pharmaceuticals Inc. - Product / Service
  • Vanda Pharmaceuticals Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations